131 related articles for article (PubMed ID: 9568464)
1. Glutathione and HIV infection: reduced reduced, or increased oxidized?
Staal FJ
Eur J Clin Invest; 1998 Mar; 28(3):194-6. PubMed ID: 9568464
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.
Aukrust P; Svardal AM; Müller F; Lunden B; Berge RK; Ueland PM; Frøland SS
Blood; 1995 Jul; 86(1):258-67. PubMed ID: 7795231
[TBL] [Abstract][Full Text] [Related]
3. Glutathione homeostasis is disturbed in CD4-positive lymphocytes of HIV-seropositive individuals.
van der Ven AJ; Blom HJ; Peters W; Jacobs LE; Verver TJ; Koopmans PP; Demacker P; van der Meer JW
Eur J Clin Invest; 1998 Mar; 28(3):187-93. PubMed ID: 9568463
[TBL] [Abstract][Full Text] [Related]
4. Virological and immunological effects of antioxidant treatment in patients with HIV infection.
Müller F; Svardal AM; Nordoy I; Berge RK; Aukrust P; Frøland SS
Eur J Clin Invest; 2000 Oct; 30(10):905-14. PubMed ID: 11029606
[TBL] [Abstract][Full Text] [Related]
5. Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients.
Watson WH; Ritzenthaler JD; Peyrani P; Wiemken TL; Furmanek S; Reyes Vega AM; Burke TJ; Zheng Y; Ramirez JA; Roman J
Free Radic Biol Med; 2019 Nov; 143():55-61. PubMed ID: 31369840
[TBL] [Abstract][Full Text] [Related]
6. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants.
Aukrust P; Müller F; Svardal AM; Ueland T; Berge RK; Frøland SS
J Infect Dis; 2003 Jul; 188(2):232-8. PubMed ID: 12854078
[TBL] [Abstract][Full Text] [Related]
7. Glutathione deficiency is associated with impaired survival in HIV disease.
Herzenberg LA; De Rosa SC; Dubs JG; Roederer M; Anderson MT; Ela SW; Deresinski SC; Herzenberg LA
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1967-72. PubMed ID: 9050888
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine: potential for AIDS therapy.
Roederer M; Staal FJ; Ela SW; Herzenberg LA; Herzenberg LA
Pharmacology; 1993; 46(3):121-9. PubMed ID: 8441760
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications.
Walmsley SL; Winn LM; Harrison ML; Uetrecht JP; Wells PG
AIDS; 1997 Nov; 11(14):1689-97. PubMed ID: 9386803
[TBL] [Abstract][Full Text] [Related]
10. HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine.
Dröge W; Eck HP; Mihm S
Immunol Today; 1992 Jun; 13(6):211-4. PubMed ID: 1378279
[TBL] [Abstract][Full Text] [Related]
11. Redox imbalance and its control in HIV infection.
Nakamura H; Masutani H; Yodoi J
Antioxid Redox Signal; 2002 Jun; 4(3):455-64. PubMed ID: 12215212
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine replenishes glutathione in HIV infection.
De Rosa SC; Zaretsky MD; Dubs JG; Roederer M; Anderson M; Green A; Mitra D; Watanabe N; Nakamura H; Tjioe I; Deresinski SC; Moore WA; Ela SW; Parks D; Herzenberg LA; Herzenberg LA
Eur J Clin Invest; 2000 Oct; 30(10):915-29. PubMed ID: 11029607
[TBL] [Abstract][Full Text] [Related]
13. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study.
Look MP; Rockstroh JK; Rao GS; Barton S; Lemoch H; Kaiser R; Kupfer B; Sudhop T; Spengler U; Sauerbruch T
Eur J Clin Invest; 1998 May; 28(5):389-97. PubMed ID: 9650013
[TBL] [Abstract][Full Text] [Related]
14. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene.
Delmas-Beauvieux MC; Peuchant E; Couchouron A; Constans J; Sergeant C; Simonoff M; Pellegrin JL; Leng B; Conri C; Clerc M
Am J Clin Nutr; 1996 Jul; 64(1):101-7. PubMed ID: 8669404
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress during acute FIV infection in cats.
Webb C; Lehman T; McCord K; Avery P; Dow S
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):16-24. PubMed ID: 18079001
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant nanozyme counteracts HIV-1 by modulating intracellular redox potential.
Singh S; Ghosh S; Pal VK; Munshi M; Shekar P; Narasimha Murthy DT; Mugesh G; Singh A
EMBO Mol Med; 2021 May; 13(5):e13314. PubMed ID: 33793064
[TBL] [Abstract][Full Text] [Related]
17. Oxygen radical release by neutrophils of HIV-infected patients.
Jarstrand C; Akerlund B
Chem Biol Interact; 1994 Jun; 91(2-3):141-6. PubMed ID: 8194130
[TBL] [Abstract][Full Text] [Related]
18. Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals.
Ly J; Lagman M; Saing T; Singh MK; Tudela EV; Morris D; Anderson J; Daliva J; Ochoa C; Patel N; Pearce D; Venketaraman V
J Interferon Cytokine Res; 2015 Nov; 35(11):875-87. PubMed ID: 26133750
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress in HIV Infection and Alcohol Use: Role of Redox Signals in Modulation of Lipid Rafts and ATP-Binding Cassette Transporters.
Thangavel S; Mulet CT; Atluri VSR; Agudelo M; Rosenberg R; Devieux JG; Nair MPN
Antioxid Redox Signal; 2018 Feb; 28(4):324-337. PubMed ID: 29132227
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine: a new approach to anti-HIV therapy.
Roederer M; Ela SW; Staal FJ; Herzenberg LA; Herzenberg LA
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):209-17. PubMed ID: 1540408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
